Cancer Home > Nilutamide

Nilutamide is prescribed to treat advanced prostate cancer in men who have had surgery to remove their testicles. This medicine works to slow down the growth of cancer cells by preventing testosterone from binding to and stimulating the growth of cancer cells. It comes as a tablet that is taken once daily. Side effects may include nausea, hot flushes, and problems seeing in the dark.

What Is Nilutamide?

Nilutamide (Nilandron®) is a prescription medication approved to treat advanced prostate cancer. It is used in men who have had surgery to remove the testicles (known medically as orchiectomy or surgical castration). It belongs to a class of medicines called antiandrogens.
(Click What Is Nilutamide Used For? for more information on this topic, including possible off-label uses.)

Are There Side Effects?

Just like any medicine, nilutamide may cause side effects. However, not everyone who takes the drug will experience problems. In fact, most people tolerate it quite well.
If reactions do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious side effects are less common.
Common side effects of nilutamide include but are not limited to:
  • Hot flushes
  • Problems seeing in the dark
  • Pain
  • Nausea.
(Click Nilutamide Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.